Methods for 3D printing of poly-4-hydroxybutyrate and copolymers
US-11639024-B2 · May 2, 2023 · US
US11904529B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11904529-B2 |
| Application number | US-202318187452-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 21, 2023 |
| Priority date | Jun 11, 2018 |
| Publication date | Feb 20, 2024 |
| Grant date | Feb 20, 2024 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Methods to fabricate objects by 3D printing of poly-4-hydroxybutyrate (P4HB) and copolymers thereof have been developed. In one method, these objects are produced by continuous fused filament fabrication using an apparatus and conditions that overcome the problems of poor feeding of the filament resulting from the low softening temperature of the filament and heat creep along the fed filament. Methods using an apparatus including a heat sink, a melt tube, a heating block and nozzle, and a transition zone between the heat sink and heating block, with the melt tube extending through the heat sink, transition zone, and heat block to the nozzle are disclosed. 3D objects are also printed by fused pellet deposition (FPD), melt extrusion deposition (MED), selective laser melting (SLM), printing of slurries and solutions using a coagulation bath, and printing using a binding solution and polymer granules.
Opening claim text (preview).
The invention claimed is: 1. A method for fabricating a three-dimensional object made from a composition of poly-4-hydroxybutyrate or copolymer or blend thereof, wherein the method comprises: providing an apparatus for fused pellet deposition, the apparatus comprising (a) a heated pressurized reservoir for polymer pellets fitted at one end with a gas line, (b) a nozzle located at the opposite end of the reservoir to the gas line inlet, (c) a movable stage located underneath the nozzle, and (d) a computer programmed with 3D CAD data for the object that can control the position of the nozzle and stage; placing pellets of poly-4-hydroxybutyrate or copolymer or blend thereof in the reservoir; heating the pellets in the reservoir to a temperature of 85 to 180° C.; pressurizing the reservoir to a pressure of 650 to 2,000 kPa; and ejecting molten polymer through the nozzle to form the printed object on the stage, wherein the diameter of the nozzle is 0.1 to 1.0 mm. 2. The method of claim 1 , further comprising drying the pellets prior to heating the pellets. 3. The method of claim 1 , wherein pressurizing the reservoir comprises pressurizing the reservoir with the gas line. 4. The method of claim 1 , wherein the gas line comprises at least one of nitrogen or air. 5. The method of claim 1 , wherein the apparatus further comprises: heating jacket surrounding the reservoir; and a cap fitting arranged on one end of the reservoir. 6. The method of claim 1 , wherein the object is printed continuously without interruption of the printing process. 7. The method of claim 1 , wherein the average diameter of the pellets are from 0.05 mm to 3 mm. 8. The method of claim 1 , wherein the diameter of the nozzle is 0.15 to 0.4 mm. 9. The method of claim 1 , wherein the water content of the composition is from 1 ppm to 1,000 ppm. 10. The method of claim 1 , wherein cells are incorporated into the object during or after printing. 11. The method of claim 1 , wherein the ejecting step includes printing the object with print lines, wherein the dimensions of the print lines are within 10% of the expected dimensions of the print lines. 12. The method of claim 1 , wherein the poly-4-hydroxybutyrate or copolymer or blend thereof further comprises one or more of the following: poly(lactide); poly(glycolide); poly(lactide-co-glycolide); poly(lactic acid); poly(glycolic acid); poly(lactic acid-co-glycolic acid); polycaprolactone; poly(orthoester); polyanhydride; poly(phosphazene); polyhydroxyalkanoate; synthetically or biologically prepared polyester, polyester with one or more of the following monomeric units: glycolic, lactic, trimethylene carbonate, p-dioxanone, or ε-caprolactone); poly(lactide-co-caprolactone); polycarbonate; tyrosine polycarbonate; polyamide; polypeptide; polyesteramide; poly(dioxanone); poly(alkylene alkylate); polyether, polyethylene glycol, polyvinyl pyrrolidone; polyurethane; polyetherester; polyacetal; polycyanoacrylate; poly(oxyethylene)/poly(oxypropylene) copolymer; polyacetal, polyketal; polyphosphate; phosphorous-containing polymer; polyphosphoester; polyalkylene oxalate; polyalkylene succinate; poly(maleic acid); chitin; chitosan; modified chitosan; polysaccharides; alginate; silk; glycerol; gelatin; hyaluronic acid and derivatives thereof; collagen; polyvinyl alcohol; and hydrogels. 13. The method of claim 1 , wherein the step of heating the pellets in the reservoir comprises heating the pellets to a temperature of 120 to 150° C. 14. A medical implant formed by the method of claim 1 . 15. The implant of claim 14 , wherein the bioactive agent is selected from the group comprising: small-molecule drugs, anti-inflammatory agents, immunomodulatory agents, molecules that promote cell migration, molecules that promote or retard cell division, molecules that promote or retard cell proliferation and differentiation, molecules that stimulate phenotypic modification of cells, molecules that promote or retard angiogenesis, molecules that promote or retard vascularization, molecules that promote or retard extracellular matrix disposition, signaling ligands, platelet rich plasma, peptides, proteins, glycoproteins, anesthetics, hormones, antibodies, growth factors, fibronectin, laminin, vitronectin, integrins, antimicrobials, antibacterial drugs, antiviral agents, antifungal agents, anti-parisitic drugs, steroids, hydroxyapatite, silver particles, vitamins, non steroidal anti-inflammatory drugs, chitosan and derivatives thereof, alginate and derivatives thereof, collagen, sugars, polysaccharides, nucleotides, oligonucleotides, lipids, lipoproteins, hyaluronic acid and derivatives thereof, allograft material, xenograft material, ceramics, nucleic acid molecules, antisense molecules, aptamers, siRNA, and nucleic acids.
using filamentary material being melted, e.g. fused deposition modelling [FDM] · CPC title
Macromolecular materials · CPC title
obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds · CPC title
using layers of powder being selectively joined, e.g. by selective laser sintering or melting · CPC title
Heads; Nozzles · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.